Concerns that well-funded Chinese companies will swoop in to grab new ideas for their own drug development are shaping an industry unaccustomed to such secrecy.
Category: Biotechnology and Bioengineering
-
Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing
The New York Times – Business: -
F.D.A. Rejects Closely Watched Lung Cancer Drug From China
The New York Times – Business:The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
-
U.S. Restricts Trade With Chinese Genomics Company
The New York Times – Business:The move will block shipments from BGI, a major Chinese firm that U.S. officials allege is associated with forced labor and the abuse of minority groups.
-
Europe Hurries to Fund More Cutting-Edge Businesses to Compete with China and U.S.
The New York Times – Business:European governments, facing a nearly $1 trillion gap in investment funding, are casting a wide net to back start-ups developing pioneering technologies.
-
How to Turn a Chicken Egg Into a Drug Factory
The New York Times – Business:A biotech start-up is testing a novel way of efficiently producing pharmaceutical drugs.
